Adocia is a clinical-stage biotechnology company that specializes in the research and development of innovative formulations of already-approved therapeutic proteins. It operates in the diabetes and other metabolic diseases field. The Company's proprietary technological platform known as BioChaperone is designed to enhance the effectiveness and safety of therapeutic proteins and their ease of use for patients.
Market capitalization (14-Sept-2021)
Closing stock price (14-Sept-2021)
When was Adocia founded?
Adocia was founded in 2005.
Who are Adocia key executives?
Adocia's key executives are Olivier Soula, Valérie Danaguezian and Olivier Martinez.
How many employees does Adocia have?
Adocia has 116 employees.
Who are Adocia competitors?
Competitors of Adocia include Neuro-Bio, Citryll and Clover Biopharmaceuticals.
Where is Adocia headquarters?
Adocia headquarters is located at 115 Avenue Lacassagne, Lyon-3E-Arrondissement.
Where are Adocia offices?
Adocia has an office in Lyon-3E-Arrondissement.
How many offices does Adocia have?
Adocia has 1 office.
Receive alerts for 300+ data fields across thousands of companies